Results 231 to 240 of about 102,475 (311)

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, Volume 50, Issue 5, Page 714-720, May 2026.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutations. [PDF]

Res Pract Thromb Haemost
Seidizadeh O, Mollica L, Giana D, Baronciani L, Colpani P, Sicuro L, Cairo A, Peyvandi F.   +7 more
europepmc   +1 more source

Pediatric Versus Adult Shear‐Induced Hemolysis: Are Age‐Related Blood Properties the Main Cause for Differences?

Artificial Organs, Volume 50, Issue 5, Page 721-729, May 2026.
Graphical summary of the experimental comparison of shear‐induced hemolysis in pediatric and adult blood using a Couette shearing device. Pediatric blood shows a trend toward lower increase in hemolysis at higher shear stress amplitudes, while no relevant differences are observed at low and intermediate stresses.
Vera Froese, Meike Fahrenholz, Ulrich Kertzscher, Michael Lommel, Maren Kleine‐Brueggeney   +4 more
wiley   +1 more source

Key residues regulating von Willebrand factor A1/A2 interactions: insights from molecular dynamics simulations and experimental validation. [PDF]

Res Pract Thromb Haemost
Fang J, Wu Z, Yang J, Huang Y, Liu A, Lin J.   +5 more
europepmc   +1 more source

Standardization of In Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development

Artificial Organs, Volume 50, Issue 5, Page 674-688, May 2026.
ABSTRACT Extracorporeal life support (ECLS) technology has witnessed remarkable advancements during the last decades. However, further research and development of devices are required to increase, for example, performance‐efficiency, hemocompatibility, and long‐term stability.
Jutta Arens, Mirko Belliato, Lars Mikael Broman, Johanna C. Clauser, Dirk W. Donker, Roberto Lorusso, Maximilian Malfertheiner, Sasa Rajsic, Justyna Swol, Leen Vercaemst, Lisa Prahl Wittberg, on behalf of the EACTS Innovation Committee, Section CPB, ECLS & MCS, the EuroELSO Innovation Group, Jutta Arens, Mirko Belliato, Lars Mikael Broman, Johanna C. Clauser, Matteo Di Nardo, Dirk Donker, Lorenzo Grazioli, Johannes Heinze, Roberto Lorusso, Maximilian Malfertheiner, Matthias Menne, Sasa Rajsic, Lena Schlotterhose, Niklas Steuer, Justyna Swol, Leen Vercaemst, Jutta Arens. Section Members, Lars Mikael Broman, Johanna C. Clauser, Renard Haumann, Michael Hübler, David Kalfa, Timur Lesbekov, Lisa Prahl Wittberg, Thomas Schlöglhofer, Zuzana Tucanova, André Vincentelli   +41 more
wiley   +1 more source

Bleeding Disorders in Children With Genetic Diseases: A Narrative Review

Acta Paediatrica, Volume 115, Issue 5, Page 1015-1024, May 2026.
ABSTRACT Aim The lack of data on bleeding risk assessment in children with genetic diseases is concerning given their increased care needs and risk of haemorrhagic complications compared to the general population. Identification of haemostatic disorders is crucial for implementing preventive measures and mitigating bleeding risk.
Raphaelle Cagol, Mariam Sbeity Barakat, Marjolaine Willems, Tasnime Akbaraly, Biron‐Andreani Christine, Isabelle Diaz, Alexandre Theron   +6 more
wiley   +1 more source

Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4066-4081, May 2026.
Abstract Aims Renal microvascular dysfunction is a central driver of diabetic kidney disease, yet the potential for rapid therapeutic reversal remains obscure. We investigated the effect of short‐term liraglutide on early changes in the renal microcirculation post‐induction of diabetes.
Yuan Li, Weiqi Liu, Yingyu Wang, Bing Wang, Xiang Xu, Bingwei Li, Mingming Liu, Xu Zhang, Ruijuan Xiu   +8 more
wiley   +1 more source

Uniaxial cyclic stretch regulates the expression of thrombomodulin and von Willebrand factor on endothelial cells. [PDF]

Blood Vessel Thromb Hemost
Giannetti A, Génot E, Perez-Martin A, Faure E, Gris JC, Cardoso M, Goze-Bac C, Benistant C, Abkarian M.   +8 more
europepmc   +1 more source

Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival

European Journal of Haematology, Volume 116, Issue 5, Page 545-557, May 2026.
ABSTRACT Background Polycythemia vera (PV) and essential thrombocythemia (ET) are associated with a well‐recognized increased risk of thrombotic events, bleeding, and all‐cause mortality, but the frequency of these outcomes during treatment has rarely been assessed in large cohorts.
Anneli Enblom Larsson, Henrik Renlund, Björn Andréasson, Henrik Holmberg, Maria Liljeholm, Anders Själander   +5 more
wiley   +1 more source